title: The serotonin 5-HT7 receptors: two decades of research.
abstract: Like most neurotransmitters, serotonin possesses a simple structure. However, the pharmacological consequences are more complex and diverse. Serotonin is involved in numerous functions in the human body including the control of appetite, sleep, memory and learning, temperature regulation, mood, behavior, cardiovascular function, muscle contraction, endocrine regulation, and depression. Low levels of serotonin may be associated with several disorders, namely increase in aggressive and angry behaviors, clinical depression, Parkinson's disease, obsessive-compulsive disorder, eating disorders, migraine, irritable bowel syndrome, tinnitus, and bipolar disease. These effects are mediated via different serotonin (5-HT) receptors. In this review, we will focus on the last discovered member of this serotonin receptor family, the 5-HT7 receptor. This receptor belongs to the G protein-coupled receptor superfamily and was cloned two decades ago. Later, different splice variants were described but no major functional differences have been described so far. All 5-HT7 receptor variants are coupled to Gαs proteins and stimulate cAMP formation. Recently, several interacting proteins have been reported, which can influence receptor signaling and trafficking.
authors.affiliation: Laboratory for Eukaryotic Gene Expression and Signal Transduction (LEGEST), Ghent University, Proeftuinstraat 86, 9000, Ghent, Belgium.
authors.forename: Evelien
authors.initials: E
authors.lastname: Gellynck
authors.forename: Karen
authors.initials: K
authors.lastname: Heyninck
authors.forename: Kjetil W
authors.initials: KW
authors.lastname: Andressen
authors.forename: Guy
authors.initials: G
authors.lastname: Haegeman
authors.forename: Finn Olav
authors.initials: FO
authors.lastname: Levy
authors.forename: Peter
authors.initials: P
authors.lastname: Vanhoenacker
authors.forename: Kathleen
authors.initials: K
authors.lastname: Van Craenenbroeck
mesh_terms: D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D006801:Humans; D009154:Mutation / Q000235:genetics; D011985:Receptors, Serotonin / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D012701:Serotonin / Q000737:chemistry / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D011985:Receptors, Serotonin; C078730:serotonin 5 receptor; C104425:serotonin 7 receptor; D012701:Serotonin; D000242:Cyclic AMP
references.citation: J Cell Sci. 2006 Oct 15;119(Pt 20):4276-84
references.pmid: 17003106
references.citation: Behav Brain Res. 2009 Aug 24;202(1):102-13
references.pmid: 19447286
references.citation: J Neurochem. 1997 Apr;68(4):1372-81
references.pmid: 9084407
references.citation: J Neurochem. 1995 Aug;65(2):782-90
references.pmid: 7616236
references.citation: Mol Pharmacol. 2009 Sep;76(3):552-9
references.pmid: 19509219
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1375-80
references.pmid: 12529502
references.citation: J Biol Chem. 1993 Aug 25;268(24):18200-4
references.pmid: 8394362
references.citation: Life Sci. 2001 Oct 12;69(21):2467-75
references.pmid: 11693255
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2001 Jun;363(6):620-32
references.pmid: 11414657
references.citation: Endocr Res. 2002 Nov;28(4):651-5
references.pmid: 12530678
references.citation: Neuropharmacology. 1997 Apr-May;36(4-5):419-28
references.pmid: 9225265
references.citation: Mol Pharmacol. 2006 Oct;70(4):1264-70
references.pmid: 16870886
references.citation: Biochim Biophys Acta. 2009 Nov;1793(11):1646-55
references.pmid: 19715731
references.citation: Recept Channels. 1995;3(1):61-70
references.pmid: 8589994
references.citation: FEBS J. 2012 Jun;279(11):1994-2003
references.pmid: 22448645
references.citation: Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):81-90
references.pmid: 14965246
references.citation: Oncogene. 2001 Mar 26;20(13):1532-9
references.pmid: 11313899
references.citation: J Neurochem. 2000 Sep;75(3):1283-93
references.pmid: 10936212
references.citation: J Chem Neuroanat. 2002 Jun;24(1):65-74
references.pmid: 12084412
references.citation: Curr Drug Targets. 2012 Jan;13(1):28-52
references.pmid: 21777185
references.citation: Mol Pharmacol. 1993 Aug;44(2):229-36
references.pmid: 8394987
references.citation: J Neurosci. 1999 Nov 1;19(21):9271-80
references.pmid: 10531431
references.citation: J Biol Chem. 1998 Jul 10;273(28):17469-76
references.pmid: 9651336
references.citation: Br J Pharmacol. 2002 Mar;135(6):1563-71
references.pmid: 11906971
references.citation: Neuroscience. 2004;124(4):901-11
references.pmid: 15026130
references.citation: Recept Channels. 2003;9(2):107-16
references.pmid: 12916471
references.citation: Mol Pharmacol. 2000 Jun;57(6):1132-41
references.pmid: 10825383
references.citation: J Biol Chem. 2005 Sep 2;280(35):30741-50
references.pmid: 15970592
references.citation: J Cell Sci. 2012 May 15;125(Pt 10):2486-99
references.pmid: 22357950
references.citation: J Neurochem. 2006 Sep;98(6):1985-98
references.pmid: 16945110
references.citation: J Neurochem. 2009 Apr;109(1):182-92
references.pmid: 19166508
references.citation: Trends Pharmacol Sci. 2005 Mar;26(3):131-7
references.pmid: 15749158
references.citation: Pharmacol Ther. 2004 Sep;103(3):203-21
references.pmid: 15464590
references.citation: Mol Neurobiol. 2011 Jun;43(3):228-53
references.pmid: 21424680
references.citation: J Invest Dermatol. 2007 Aug;127(8):1947-55
references.pmid: 17429435
references.citation: Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8547-51
references.pmid: 8397408
references.citation: Cell Signal. 2007 Feb;19(2):278-88
references.pmid: 16935469
references.citation: Mol Pharmacol. 2006 Jan;69(1):207-15
references.pmid: 16189297
references.citation: Pharmacogenetics. 2003 Feb;13(2):119-26
references.pmid: 12563181
references.citation: J Theor Biol. 1996 Aug 21;181(4):381-97
references.pmid: 8949584
references.citation: Neuropharmacology. 1998 Dec;37(12):1621-32
references.pmid: 9886685
references.citation: FEBS J. 2005 May;272(9):2304-16
references.pmid: 15853814
references.citation: J Neurochem. 2005 May;93(3):549-59
references.pmid: 15836614
references.citation: J Biol Chem. 1999 Aug 6;274(32):22569-80
references.pmid: 10428835
references.citation: Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):39-51
references.pmid: 14965243
references.citation: Nature. 2013 Feb 14;494(7436):185-94
references.pmid: 23407534
references.citation: J Biol Chem. 1996 Dec 27;271(52):33308-16
references.pmid: 8969190
references.citation: Genomics. 1995 Mar 20;26(2):207-9
references.pmid: 7601444
references.citation: Nature. 2011 Jul 19;477(7366):549-55
references.pmid: 21772288
references.citation: Neuropharmacology. 2005 Jul;49(1):40-7
references.pmid: 15992579
references.citation: Hippocampus. 2012 Apr;22(4):762-71
references.pmid: 21484935
references.citation: Mol Cell Biochem. 2002 Sep;238(1-2):81-8
references.pmid: 12349912
references.citation: Neuropharmacology. 1999 Aug;38(8):1083-152
references.pmid: 10462127
references.citation: Neuropharmacology. 2003 Jun;44(8):1031-7
references.pmid: 12763096
references.citation: J Pharmacol Exp Ther. 2011 Feb;336(2):296-302
references.pmid: 21030484
references.citation: Trends Pharmacol Sci. 2000 Feb;21(2):70-7
references.pmid: 10664612
references.citation: Mol Pharmacol. 2009 Feb;75(2):374-80
references.pmid: 18996971
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1999 Jun;359(6):454-9
references.pmid: 10431755
references.citation: J Pharmacol Exp Ther. 1998 Nov;287(2):508-14
references.pmid: 9808674
references.citation: Ann N Y Acad Sci. 1998 Dec 15;861:31-7
references.pmid: 9928236
references.citation: J Lab Clin Med. 1948 Dec;33(12):1606
references.pmid: 18100169
references.citation: Endocrinology. 2002 May;143(5):1748-60
references.pmid: 11956157
references.citation: Mol Psychiatry. 1996 Nov;1(5):392-7
references.pmid: 9154233
references.citation: J Neurochem. 2005 Jan;92(1):72-82
references.pmid: 15606897
references.citation: J Pharmacol Exp Ther. 2012 Aug;342(2):429-40
references.pmid: 22570363
references.citation: J Pharmacol Exp Ther. 2005 Jun;313(3):1003-10
references.pmid: 15716386
references.citation: J Neurochem. 1994 Aug;63(2):456-64
references.pmid: 7518496
references.citation: Neurochem Int. 2008 Feb;52(3):419-25
references.pmid: 17881091
references.citation: Pharmacol Ther. 2011 Feb;129(2):120-48
references.pmid: 20923682
references.citation: Br J Pharmacol. 2009 Sep;158(1):5-14
references.pmid: 19309353
references.citation: J Biol Chem. 2003 Jan 31;278(5):3098-104
references.pmid: 12446729
references.citation: Neuroscience. 2001;102(2):361-7
references.pmid: 11166122
references.citation: Blood. 2007 Apr 15;109(8):3139-46
references.pmid: 17158224
references.citation: J Physiol. 2002 Jan 1;538(Pt 1):41-51
references.pmid: 11773315
references.citation: Biochem Pharmacol. 2004 Nov 1;68(9):1787-96
references.pmid: 15450944
references.citation: Fed Proc. 1983 Feb;42(2):213-7
references.pmid: 6337063
references.citation: Brain Res Rev. 2008 Aug;58(2):415-52
references.pmid: 18222544
references.citation: J Neurochem. 2003 Dec;87(5):1076-85
references.pmid: 14622088
references.citation: J Neurochem. 2004 May;89(3):766-75
references.pmid: 15086532
references.citation: Neurosci Lett. 2012 Mar 9;511(2):65-9
references.pmid: 22285262
references.citation: Gene. 2008 Dec 15;426(1-2):23-31
references.pmid: 18793707
references.citation: Neuropharmacology. 2013 Apr;67:155-67
references.pmid: 23164613
references.citation: Curr Opin Neurobiol. 1997 Jun;7(3):391-6
references.pmid: 9232797
references.citation: Behav Brain Res. 2008 Dec 16;195(1):198-213
references.pmid: 18571247
references.citation: Cell Signal. 2012 May;24(5):1053-63
references.pmid: 22245496
references.citation: Curr Neuropharmacol. 2007 Dec;5(4):224-31
references.pmid: 19305739
references.citation: Science. 2002 Jul 26;297(5581):615-20
references.pmid: 12142540
references.citation: J Neurochem. 2003 Oct;87(1):22-9
references.pmid: 12969249
references.citation: Mol Pharmacol. 2007 Jul;72(1):8-17
references.pmid: 17392525
references.citation: Mol Pharmacol. 1999 Nov;56(5):1014-24
references.pmid: 10531408
references.citation: FEBS Lett. 1997 Jul 28;412(2):321-4
references.pmid: 9256244
references.citation: Biol Psychiatry. 2005 Nov 15;58(10):831-7
references.pmid: 16018977
references.citation: Mol Pharmacol. 2001 Dec;60(6):1349-55
references.pmid: 11723242
references.citation: Br J Pharmacol. 1999 Sep;128(1):158-64
references.pmid: 10498847
references.citation: Br J Pharmacol. 2002 Oct;137(3):345-52
references.pmid: 12237254
references.citation: J Biol Chem. 2000 Aug 4;275(31):23620-6
references.pmid: 10816555
references.citation: DNA Cell Biol. 1993 Jun;12(5):401-9
references.pmid: 8517926
references.citation: J Neurosci. 2005 Aug 24;25(34):7821-30
references.pmid: 16120784
references.citation: J Biol Chem. 2003 Jun 13;278(24):21576-83
references.pmid: 12682077
references.citation: Neuron. 1993 Sep;11(3):449-58
references.pmid: 8398139
references.citation: Biochem Biophys Res Commun. 2002 Feb 1;290(4):1300-7
references.pmid: 11812005
references.citation: Gene. 2003 Nov 13;319:137-48
references.pmid: 14597179
references.citation: Pharmacol Rev. 1994 Jun;46(2):157-203
references.pmid: 7938165
references.citation: Biochem Biophys Res Commun. 2005 Apr 8;329(2):684-92
references.pmid: 15737640
references.citation: J Biol Chem. 1993 Nov 5;268(31):23422-6
references.pmid: 8226867
references.citation: Mol Pharmacol. 2000 Jan;57(1):162-70
references.pmid: 10617691
references.citation: Behav Brain Res. 2005 Aug 30;163(1):136-40
references.pmid: 15936093
references.citation: Behav Brain Res. 2004 Dec 6;155(2):275-82
references.pmid: 15364487
references.citation: Eur J Pharmacol. 2006 Feb 17;532(1-2):1-10
references.pmid: 16487959
references.citation: Psychopharmacology (Berl). 2010 Dec;212(4):687-97
references.pmid: 20827463
references.citation: J Biol Chem. 1948 Dec;176(3):1243-51
references.pmid: 18100415
references.citation: Br J Pharmacol. 2003 Apr;138(7):1210-4
references.pmid: 12711620